Global Phacoemulsification Equipment Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Phacoemulsification Equipment Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.82 billion by 2031, growing at a CAGR of 6.9% during the forecast period of 2023–2031. The rising incidence of cataracts globally, combined with technological innovations in ophthalmic surgical devices, is fueling the demand for phacoemulsification equipment. Increasing geriatric population, growing awareness of eye health, and a shift towards minimally invasive surgeries are further contributing to market growth. The preference for phacoemulsification over traditional methods due to reduced healing time and better visual outcomes is boosting adoption in both developed and emerging markets.

Drivers:

1. Increasing Prevalence of Cataracts:

Cataracts remain the leading cause of blindness globally. With the aging population on the rise, especially in Asia-Pacific and Europe, the number of cataract surgeries is increasing, thereby driving demand for phacoemulsification equipment.

2. Technological Advancements in Ophthalmic Devices:

Recent innovations in phacoemulsification systems—including micro-incision surgery (MICS), intelligent fluidics management, and enhanced energy control—are enabling safer, faster, and more efficient surgeries.

3. Growth in Outpatient Ophthalmic Surgery Centers:

The shift towards ambulatory surgical centers (ASCs) for cataract surgery is supporting demand for portable, easy-to-use phacoemulsification systems, especially in regions with expanding healthcare infrastructure.

Restraints:

1. High Cost of Equipment and Surgery:

Advanced phacoemulsification systems can be expensive for smaller clinics and providers in developing regions. Additionally, the cost of surgery, including consumables and post-op care, can be a barrier in low-income areas without insurance coverage.

2. Shortage of Skilled Ophthalmic Surgeons:

Despite demand, the lack of trained ophthalmic surgeons in some regions—especially rural or underdeveloped areas—limits the widespread use of phacoemulsification systems.

Opportunity:

1. Expanding Healthcare Access in Emerging Markets:

Rapid improvements in healthcare infrastructure and growing investments in eye care across Asia-Pacific, Africa, and Latin America provide substantial opportunities for market expansion.

2. Integration of AI and Digital Imaging:

The use of artificial intelligence and real-time intraoperative imaging in phacoemulsification devices enhances precision and patient outcomes. This integration is opening avenues for advanced product development and market differentiation.

Market by System Type Insights:

Based on system type, the Ultrasound Phacoemulsification Systems segment dominated the market in 2023. These systems remain the standard due to their proven effectiveness and precision. However, Femtosecond Laser-Assisted Phacoemulsification Systems are gaining traction and expected to grow at the highest CAGR, driven by improved outcomes and rising adoption in high-volume eye care centers.

Market by End-use Insights:

Hospitals accounted for the largest market share in 2023, as they are well-equipped with advanced surgical infrastructure and trained personnel. However, Ambulatory Surgical Centers (ASCs) are expected to witness the fastest growth due to increased cost efficiency, shorter recovery times, and growing preference for outpatient cataract procedures.

Market by Regional Insights:

In 2023, North America held the largest share of the global phacoemulsification equipment market, supported by high cataract surgery volumes, favorable reimbursement policies, and strong adoption of advanced surgical technologies. However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period due to the large aging population, rising awareness, and increasing healthcare investments in countries such as China and India.

Competitive Scenario:

Key players in the Global Phacoemulsification Equipment Market include Alcon Inc., Johnson & Johnson Vision, Carl Zeiss Meditec AG, Bausch + Lomb, NIDEK Co., Ltd., Topcon Corporation, and Appasamy Associates. These companies are focusing on developing advanced phacoemulsification platforms, expanding into emerging markets, and engaging in strategic partnerships to strengthen their global presence.

Scope of Work – Global Phacoemulsification Equipment Market

Report Metric Details

Market Size (2023) USD 1.1 Billion

Projected Market Size (2031) USD 1.82 Billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Ultrasound, Laser-Assisted), By End-use (Hospitals, ASCs)

Growth Drivers Rising cataract prevalence, tech innovation, outpatient surgery adoption

Opportunities Emerging market access, AI-integrated surgical systems

Key Market Developments:

2023: Alcon launched the Centurion Vision System with Active Sentry Hand